Literature DB >> 2818446

The effects of the propranolol enantiomers on the intracardiac electrophysiological activities of Langendorff perfused hearts.

G Stark1, U Stark, A Lueger, H Bertuch, E Pilger, B Pietsch, H A Tritthart, W Lindner.   

Abstract

The optical isomers of the beta blocking agent propranolol exert beta receptor blocking as well as membrane stabilizing effects. The latter is thought to be responsible for the antiarrhythmic effect of the drug. In this study we quantified the electrophysiological effects of both isomers of propranolol on the conduction and pacemaker system of the heart. The experiments were performed on isolated hearts using a special ECG recording and stimulation technique. To abolish isoproterenol's beta adrenergic stimulatory effect on heart rate, 30-times higher concentrations of (+)propranolol were necessary than of (-)propranolol in order to be consistent. Both isomers caused a similar and marked slowing of conduction velocity through the bundle of His and ventricular myocardium. Also, heart rate, as well as atrio-ventricular conduction velocity were significantly slowed by a concentration of 10 microM of either drug, (-)propranolol being slightly more effective. Only in the presence of (-)propranolol did significant changes of atrio-ventricular and His-bundle conduction occur at a concentration of 1 microM. During programmed stimulation sinus node recovery time was more prolonged by (-)propranolol than during perfusion with (+)propranolol. The highest rate of pacing with 1:1 conduction of the sino-atrial conduction, the atrial and ventricular myocardium was significantly depressed to a comparable degree by either isomers of propranolol. These effects appear to be primarily responsible for the antiarrhythmic effects of both isomers. Because of the minor effects of (+)propranolol on sinus- and AV-node activity, as well as on beta adrenergic receptors, this isomer may have potential clinical importance in the treatment of arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818446     DOI: 10.1007/BF01908198

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  16 in total

Review 1.  The clinical pharmacology of lidocaine as an antiarrhythymic drug.

Authors:  K A Collinsworth; S M Kalman; D C Harrison
Journal:  Circulation       Date:  1974-12       Impact factor: 29.690

2.  Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazine.

Authors:  A Langslet
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

3.  Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.

Authors:  S N Singh; R DiBianco; M E Davidov; J S Gottdiener; W L Johnson; A R Laddu; R D Fletcher
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

4.  Steady state and time-dependent slowing of conduction in canine hearts. Effects of potassium and lidocaine.

Authors:  S Saito; C M Chen; L S Gettes; M R Lynch
Journal:  Circ Res       Date:  1978-02       Impact factor: 17.367

5.  Optical isomers of propranolol.

Authors:  R Howe; R G Shanks
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

6.  The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias.

Authors:  A M Barrett; V A Cullum
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

7.  Continuous ECG measurements of intracardiac activity from the surface of Langendorff-perfused guinea pig hearts.

Authors:  G Stark; U Huber; E Hofer; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1987 Sep-Oct       Impact factor: 17.165

8.  Catecholamine release and potassium accumulation in the isolated globally ischemic rabbit heart.

Authors:  A A Wilde; R J Peters; M J Janse
Journal:  J Mol Cell Cardiol       Date:  1988-10       Impact factor: 5.000

9.  The effects of propranolol stereoisomers on nomotopic and ectopic cardiac automaticity in the rat.

Authors:  E Roman; F Ruiz; D Perez; J Hernández
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1987-10

10.  Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart.

Authors:  W F Lubbe; C A Muller; M Worthington; E L McFadyen; L H Opie
Journal:  Cardiovasc Res       Date:  1981-12       Impact factor: 10.787

View more
  2 in total

1.  Stereoselective propranolol metabolism in two drug induced rat hepatic microsomes.

Authors:  Xin Li; Su Zeng
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma.

Authors:  Caroline T Seebauer; Matthew S Graus; Lan Huang; Alex McCann; Jill Wylie-Sears; Frank Fontaine; Tara Karnezis; David Zurakowski; Steven J Staffa; Frédéric Meunier; John B Mulliken; Joyce Bischoff; Mathias Francois
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.